[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
August 5, 1922


Author Affiliations


JAMA. 1922;79(6):461-462. doi:10.1001/jama.1922.02640060043011

Recently Lukens1 called attention to the use of chaulmoogra oil in the treatment of tuberculous laryngitis, stressing the relief of pain and dysphagia which followed its use. Certainly, any agent which is capable of relieving the distress caused by an actively tuberculous larynx is worthy of the utmost consideration, and should be given a trial.

Although the use of chaulmoogra oil has been attended by quite markedly beneficial results in the treatment of leprosy and, by some, is regarded as a specific in this disease, its use in tuberculosis is still in the experimental stage. Kolmer, Davis and Jager2 have shown that the oil has no effect on virulent tubercle bacilli in their experiments on guinea-pigs, using an in vitro-vivo method. Therefore, we should not expect the oil to act as an active bactericidal agent in any lesions. Voegtlin, Smith and Johnson,3 in a more extensive set

First Page Preview View Large
First page PDF preview
First page PDF preview